source
- UCB bets $2B on Candid's T cell engager ambitionsKen Song has done it again. The biopharma veteran's all-out effort to prove T cell engagers' potential in autoimmune diseases is getting picked up by one of Europe’s oldest pharma companies. UCB is…Endpoints · 2mo ago↗ source
- Federal appeals court blocks mailing of abortion pill mifepristoneMifepristone, involved in most abortions in the U.S., can now be distributed only in person and at clinics.STAT · 3mo ago↗ source
- Opinion: What do medical students think about their education?“No one's pulling the pieces together”: a conversation with medical students about preventive care education.STAT · 3mo ago↗ source